Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16899608 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors
Condition: Metastatic Melanoma
Intervention: Drug: Anti-B-RAF

Indicates status has not been verified in more than two years